Viral Infections

This COVID-19 roundup includes research on an alternative therapy to nirmatrelvir-ritonavir, a vaccine regimen that protects pregnant women and infants against certain variants, pegylated interferon lambda...

Researchers examined the effectiveness of the monoclonal antibody, nirsevimab, in protecting infants from the respiratory syncytial virus (RSV) and RSV lower respiratory tract infection.

This COVID-19 roundup includes coverage of the FDA’s recent approval of bivalent booster vaccines for younger age groups, the use of COVID-19 PrEP and associated risk for the virus, an increase of...

The CDC examined data to determine how many people received treatment for hepatitis C virus infection in the United States within a year of diagnosis.

The US Food and Drug Administration (FDA) approved the use of JYNNEOS vaccine for individuals who are at high risk of monkeypox infection.

Researchers aimed to establish common symptoms associated with monkeypox virus infection to assist in minimizing the spread of the infection, and bringing awareness to clinicians and the public.

The authors expanded upon research conducted in 2015 by including deaths across different global demographics that did not occur in hospitals. This is the first study to examine the RSV disease burden in...

In a recent study, researchers aimed to better understand the prevalence of hepatitis C virus in the global population.

The American Academy of Pediatrics has released new recommendations for preventing and controlling influenza during the 2021-2022 season, especially in light of the continued COVID-19 pandemic.

The American Academy of Pediatrics has released interim guidance on treating respiratory syncytial virus in infants during the current atypical season.